Overall rank by patents
#41,563
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, active 2020–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Mentice holds 6 US patents across 5 technology areas, rank #41,563 of 50,000 tracked assignees.
Mentice AB has been granted 6 US utility patents between 2020 and 2024, placing Mentice AB at rank #41,563 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.7 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Mentice AB is one of the more focused assignees in the PatentsView dataset. By volume, Mentice sits between Meltin MMI Co., Ltd. (6 patents, rank #41,559) and Merlin MD PTE Ltd. (6 patents, rank #41,567) - the closest US assignees by grant volume. The composite Innovation Score of 30.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2024, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Mentice AB's 15.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Mentice AB against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MELTIN MMI CO., LTD.
6 patents
MEMC Electronic Materials S.P.A.
6 patents
MEMC Singapore Pte. Ltd.
6 patents
MEMSIC, INC.
6 patents
MEOPTA—OPTIKA, S.R.O.
6 patents
MEPROLIGHT (1990) LTD.
6 patents
MERCIA PHARMA, INC.
6 patents
MERLIN MD PTE LTD.
6 patents
MENTICE AB
6 patents
What this shows Mentice holds 6 patents at rank #41,563, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #41,563 in granted patent volume.
Other assignees with the most granted patents in Mentice's primary technology class.
Mentice's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
31 Top 65% higher than 35% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 16.7% |
| 2021 | 2 | 33.3% |
| 2022 | 1 | 16.7% |
| 2023 | 1 | 16.7% |
| 2024 | 1 | 16.7% |
Top 5 of 5 technology areas
Overall rank by patents
#41,563
Across all tracked assignees
30.7 out of 100
How to use this portfolio
Mentice's 6 grants land it in the top 65% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.